Skip to content

Effect of electroacupuncture combined with individualized positive end-expiratory pressure on perioperative lung injury serum markers and inflammatory factors in elderly patients undergoing spinal endoscopy.

Effect of electroacupuncture combined with individualized positive end-expiratory pressure on perioperative lung injury serum markers and inflammatory factors in elderly patients undergoing spinal endoscopy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001007
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation (LDH)

Interventions

Fixed PEEP Group:with a PEEP of 5
Individualized PEEP Group:Individualized PEEP Titrated by Dynamic Compliance (Cdyn)
Electroacupuncture Combined with Individualized PEEP Group:Electroacupuncture Combined with Cdyn-Titrated Individualized PEEP

Sponsors

Gansu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) American Society of Anesthesiologists (ASA) Physical Status Classification II–III; 2) Elderly patients (aged 60–80 years) scheduled for endoscopic spinal surgery under general anesthesia, with an estimated operative time =2 hours; 3) Understand the study content and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria 1) History of contraindications to PEEP application, such as pneumothorax, pulmonary bullae, or severe emphysema. 2) Pre-existing respiratory or pulmonary diseases (e.g., asthma, chronic bronchitis, chronic obstructive pulmonary disease). 3) Presence of a cardiac pacemaker/defibrillator, or unstable cardiac conditions (e.g., recent myocardial infarction, severe heart failure). 4) Coagulation disorders, or local skin lesions/infections at the electroacupuncture sites (hands or feet). 5) Preoperative hemodynamic instability (e.g., shock) or severe hypoxemia. 6) Long-term use of analgesics or history of alcohol abuse. Elimination criteria 1) Those who voluntarily request to withdraw from the study during the trial; 2) Those who develop serious complications during or after surgery that affect the study; 3) Those who are lost to follow-up, making it impossible to collect outcome measures; 4) Operative time >4 hours.

Design outcomes

Primary

MeasureTime frame
Soluble Receptor for Advanced Glycation End Products (sRAGE); Pulmonary Surfactant ;Clara Cell Secretory Protein (CC16);interleukin-6;interleukin-8;tumor necrosis factor-alpha;

Secondary

MeasureTime frame
Oxygenation Index (OI);Respiratory Mechanics Parameters;Incidence of Postoperative Pulmonary Complications (PPCs);lung ultrasound score;intraoperative vasoactive agent use;

Countries

China

Contacts

Public ContactWangChunai

Gansu Provincial Hospital of Traditional Chinese Medicine

chunaixx@163.com15002561282

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026